Recommendations for the Use of Etoposide-Based Therapy and Bone Marrow Transplantation for the Treatment of HLH: Consensus Statements by the HLH Steering Committee of the Histiocyte Society

Clicks: 444
ID: 117852
1970
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #2 of 10 articles by views in the journal of allergy and clinical immunology in practice

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome requiring aggressive immunosuppressive therapy. Following 2 large international studies mainly targeting pediatric patients with familial disease and patients without underlying chronic or malignant disease, th …
Reference Key
s1970therecommendations Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Ehl S;Astigarraga I;von Bahr Greenwood T;Hines M;Horne A;Ishii E;Janka G;Jordan MB;La Rosée P;Lehmberg K;Machowicz R;Nichols KE;Sieni E;Wang Z;Henter JI;;
Journal the journal of allergy and clinical immunology in practice
Year 1970
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/30201097
Keywords
medical National Center for Biotechnology Information NCBI NLM MEDLINE review humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't lymphohistiocytosis bone marrow transplantation* societies antineoplastic agents hemophagocytic / diagnosis cytotoxicity immunologic etoposide / therapeutic use* hemophagocytic / therapy* lymphocyte activation consensus health planning guidelines jan-inge henter pmid:30201097 doi:10.1016/j.jaip.2018.05.031 stephan ehl itziar astigarraga phytogenic / therapeutic use* histiocytes / immunology* lymphocytes / immunology*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.